Research news

An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.

UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.

A world-class research team at UCLH and UCL has been awarded £3.76m to carry out a countrywide trial to identify accurate and quick blood tests that can diagnose dementia.

UCLH is part of an important trial researching an investigational vaccine to potentially prevent Mpox (previously known as monkey pox) and small pox. Professor Vincenzo Libri is leading the study at the NIHR UCLH Clinical Research Facility which is aiming to recruit 350 people at sites across the UK.

UCLH and UCL researchers have successfully completed a world-first trial of a therapy designed to restore hearing loss.